Integrative Training in Therapeutic Discovery

治疗发现的综合培训

• 批准号: 7224974
• 负责人: LAWRENCE J. MARNETT
• 金额: $ 31.77万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-09-30 至 2010-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7224974
• 关键词: Internet; NIH Roadmap Initiative tag; chemotherapy; disease /disorder etiology; drug discovery /isolation; education evaluation /planning; educational resource design /development; interdisciplinary collaboration; medically underserved population; meeting /conference /symposium; mentoring /mentor; postgraduate education; therapy design /development; training

DESCRIPTION (provided by applicant): Understanding of the mechanisms of human disease is expanding at an exponential rate and the NIH Roadmap is challenging scientists to transform this knowledge into tangible health benefits for people. As a result, teams of academic investigators are formulating therapeutic hypotheses and generating the tools with which to test them. This is creating a heed for individuals with interdisciplinary training in translational medicine and chemical biology. Experience at Vanderbilt has identified a mechanism for training graduate students and postdoctoral/fellows in which they are co-mentored by physician-scientists and chemical biologists. The current application formalizes this experience into a program that will provide integrative training in therapeutic discovery. Its goal is to train graduate students and postdoctoral/fellows in the critical steps of therapeutic discovery, including identifying an unmet medical need, considering the molecular basis of the relevant disease, framing a hypothesis for a novel therapeutic approach,- and generating the lead molecules with which to test the hypothesis. Students will be recruited into the program following their first year in graduate school and postdoctoral will be recruited directly into the program. All students and postdocs will take two courses, Foundations of Chemical Biology and Therapeutic Discovery, as well as seminars in chemical biology and clinical pharmacology. The Therapeutic Discovery.course will provide introductory training in drug discovery and describe case studies in the application of an integrative approach to the discovery of new therapeutic strategies and agents. Guest lecturers will participate in the course to highlight the latest advances in disease treatment from the perspective of the individuals who made them. A community of trainees will be developed by participation in a web-based dialog among teams in both core courses, a weekly journal club, a monthly working group, and an annual retreat. Trainees will organize a symposium of extramural speakers as part of the annual retreat. Trainees will be co-mentored by individuals with expertise in translational medicine and chemical biology and their progress will be closely monitored by the Scientific Advisory Committee of the Training Program. The quality of the training provided will be evaluated annually by both an Internal Advisory Committee and an External Advisory Committee. Substantial investments in faculty recruiting and infrastructure coupled with extensive interactions between the College of Arts and Science and the School of Medicine provides a rich environment for integrative training in therapeutic discovery at Vanderbilt.

描述（由申请人提供）：对人类疾病机制的理解正在以指数速度扩展，NIH路线图正在挑战科学家将这些知识转化为人们的有形健康益处。因此，学术研究团队正在制定治疗假设，并开发测试这些假设的工具。这为在转化医学和化学生物学方面受过跨学科培训的个人创造了一个机会。在范德比尔特的经验已经确定了一种机制，培养研究生和博士后/研究员，他们是共同辅导的物理学家，科学家和化学生物学家。目前的应用程序将这种经验正式纳入一个程序，将提供治疗发现的综合培训。它的目标是培养研究生和博士后/研究员在治疗发现的关键步骤，包括确定未满足的医疗需求，考虑相关疾病的分子基础，为新的治疗方法构建假设，并生成用于测试假设的先导分子。学生将在研究生院的第一年被招募进入该计划，博士后将直接被招募进入该计划。所有学生和博士后将参加两门课程，化学生物学和治疗发现的基础，以及化学生物学和临床药理学的研讨会。治疗发现课程将提供药物发现的入门培训，并描述应用综合方法发现新治疗策略和药物的案例研究。客座讲师将参加课程，从个人的角度突出疾病治疗的最新进展。学员社区将通过参与两个核心课程团队之间的网络对话、每周期刊俱乐部、每月工作组和年度务虚会来发展。作为年度务虚会的一部分，学员将组织一次校外演讲者研讨会。学员将由具有转化医学和化学生物学专业知识的个人共同指导，他们的进展将由培训计划的科学咨询委员会密切监测。所提供培训的质量将每年由内部咨询委员会和外部咨询委员会进行评估。在教师招聘和基础设施的大量投资，加上艺术和科学学院和医学院之间的广泛互动，为范德比尔特的治疗发现综合培训提供了丰富的环境。